title: Therapeutic approaches in metastatic renal cell carcinoma.
authors.affiliation: Department of Urology, Klinikum Grosshadern, Ludwig Maximilians University Munich, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Staehler
authors.forename: Karl
authors.initials: K
authors.lastname: Rohrmann
authors.forename: Alexander
authors.initials: A
authors.lastname: Bachmann
authors.forename: Dirk
authors.initials: D
authors.lastname: Zaak
authors.forename: Christian G
authors.initials: CG
authors.lastname: Stief
authors.forename: Michael
authors.initials: M
authors.lastname: Siebels
mesh_terms: D000315:Adrenalectomy / Q000379:methods; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000379:methods; D001859:Bone Neoplasms / Q000556:secondary; D019496:Cancer Vaccines / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000556:secondary* / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007680:Kidney Neoplasms; D009392:Nephrectomy / Q000379:methods; D013792:Thalidomide / Q000627:therapeutic use
chemical_list: D020533:Angiogenesis Inhibitors; D019496:Cancer Vaccines; D013792:Thalidomide